Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gigacloud Technology Inc (GCT) vs Smith & Nephew plc (SNN) Price & Performance

Gigacloud Technology IncTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Gigacloud Technology Inc vs Smith & Nephew plc — how do they compare? Gigacloud Technology Inc trades at $37.98 (market cap $1.40B), while Smith & Nephew plc trades at $31.44 (market cap $12.81B). The key difference: Smith & Nephew plc is far larger — about 9.2× Gigacloud Technology Inc's market cap, and Smith & Nephew plc pays a 2.54% dividend while Gigacloud Technology Inc pays none. Which is the better fit depends on your goals.

GCTSNN
Market Cap
$1.40B$12.81B
Sector
TechnologyHealth
52-Week High
$51.80$38.70
52-Week Low
$20.97$28.73
Enterprise Value
$1.51B$15.58B
Dividend Yield
2.54%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gigacloud Technology Inc

GigaCloud Technology (GCT) trades at $38.01, up 7.37% on the day, showing strong momentum. The stock demonstrates robust fundamentals with a P/E of 9.5, net income margin of 10.8%, and consistent earnings beats in recent quarters. Technical indicators show a bullish overall signal despite mixed moving averages and oscillators. Recent news highlights the company's inclusion in TIME's 'World's Growth Leaders 2026' list and strong Q1 2026 results with 32% YoY revenue growth.

The outlook appears positive with analyst consensus at 'Buy' (67% buy rating), strong profitability metrics (ROE 32.1%), and expanding international presence. Key risks include potential market volatility, competitive pressures in B2B logistics, and execution risks in new market expansion. The stock presents an opportunity given its valuation multiples below growth rates and consistent operational execution.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $31.41, up 5.28% today, with a bullish technical signal from moving averages. The company shows improving fundamentals with revenue growth from $5.8B in 2024 to $6.2B projected for 2025 and net income margin expanding to 10.14%. Recent product launches in robotics and wound care, plus a $500M share buyback, highlight strategic execution. Analyst consensus is mixed with 27% buy ratings but 68% hold, reflecting cautious optimism amid earnings volatility where two of the last four quarters missed expectations.

Outlook: SNN's recovery trajectory and product innovation support long-term growth, but investor patience is needed due to earnings inconsistency and moderate debt levels. Key risks include competitive pressures in medtech and execution on guidance. The stock presents a value opportunity if operational improvements continue, trading at reasonable valuations (P/E 21.5, P/S 2.18) versus sector peers.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gigacloud Technology Inc

Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.

Read more on GCT

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN